Disintegration test for tablets and capsules

View/ Open
Citation
World Health Organization. Pharmaceuticals Unit. (1986). Disintegration test for tablets and capsules. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/59134
Description
WHO/PHARM/86.524. UnpublishedEnglish only
2 p.
Gov't Doc #
WHO/PHARM/86.524. UnpublishedCollections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
Fact sheet on lopinavir and ritonavir (LPV/R) oral pellets: 40 mg/10 mg per capsule bottle pack cointaining 120 capsules
World Health Organization; Interagency Task Team (IATT) on Prevention of HIV Infection in Pregnant Women, Mothers and their Children; UNICEF (2015) -
Policy brief: supply planning for new dosage form of lopinavir and ritonavir oral pellets: 40 mg/10 mg per capsule, pack of 120 capsules
World Health Organization; Interagency Task Team (IATT) on Prevention of HIV Infection in Pregnant Women, Mothers and their Children; UNICEF (2015) -
Capsules
World Health Organization. Pharmaceuticals Unit (WHO/PHARM/86.520. Unpublished, 1986)